文献速递焦虑、强迫与应激相关障碍

个性化fMRI引导的TMS靶向威胁神经环路治疗PTSD:一项随机临床试验

Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial.
PubMed 文献 · Am J Psychiatry · 2026-04-02

这项双盲随机临床试验将50名有PTSD症状的成人分配至10次每日两次的1Hz TMS或假TMS,TMS靶点为右侧背外侧前额叶皮层中与右侧杏仁核功能连接最强的fMRI引导位点。主动TMS较假TMS显著降低右侧杏仁核威胁反应性,但皮肤电反应无显著组间差异;治疗后至随访期间,主动TMS较假TMS显著改善高唤醒和总PTSD症状。

要点

  • fMRI引导的个性化TMS靶向右侧杏仁核相关威胁环路可降低其威胁反应性。
  • 主动TMS在随访时显著改善高唤醒和总PTSD症状,但治疗后即刻组间无差异。
  • 皮肤电反应性未观察到显著TMS效应。

核心结论

  • 个性化fMRI引导的TMS靶向威胁神经环路可降低杏仁核威胁反应性并改善随访期PTSD症状。

研究设计与样本

  • 双盲随机临床试验纳入50名有PTSD症状的成人,随机接受10次每日两次的1Hz TMS或假TMS。
  • TMS靶点为fMRI引导的右侧背外侧前额叶皮层中与右侧杏仁核功能连接最强的位点。

主要发现

  • 主动TMS较假TMS显著降低右侧杏仁核威胁反应性。
  • 皮肤电反应性未观察到显著TMS效应。
  • TMS前后两组均见高唤醒和总PTSD症状显著下降,但组间无显著差异。
  • 从TMS前至随访(TMS后3至6个月),主动TMS较假TMS显著降低高唤醒和总PTSD症状。
  • 敏感性分析显示临床结果稳健。

关键数值与推荐

  • 主要结局为fMRI评估的右侧杏仁核威胁反应性和创伤回忆时的皮肤电反应性,于TMS前后测量。
  • 次要结局为基于DSM-5 PTSD检查表的高唤醒和总PTSD症状,于TMS前后及TMS后3至6个月随访时测量。

临床怎么用

  • 针对威胁神经环路的个性化fMRI引导TMS可能作为PTSD的神经调控治疗选择。
  • 短期组间症状差异不显著,需关注随访期疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Transcranial magnetic stimulation (TMS) has shown promise in reducing posttraumatic stress disorder (PTSD) symptoms, with varied clinical results. A mechanistic understanding is needed to personalize treatment and improve response rates. The threat neurocircuitry, specifically the right amygdala, has consistently been implicated in PTSD pathophysiology. This neuroscience-informed trial aimed to modulate the threat neurocircuitry using functional MRI (fMRI)-guided TMS to treat PTSD. METHODS: In a double-blind clinical trial, 50 adults with PTSD symptoms were randomized to 10 twice-daily sessions of either 1-Hz TMS or sham TMS. TMS was delivered to an fMRI-guided target within the right dorsolateral prefrontal cortex with the strongest functional connection to the right amygdala. The primary outcomes were right amygdala threat reactivity, assessed by fMRI, and skin conductance reactivity during trauma recall, measured pre- and post-TMS. The secondary outcomes were hyperarousal and total PTSD symptoms (based on the PTSD Checklist for DSM-5), measured pre- and post-TMS and at a follow-up assessment between 3 and 6 months after TMS. RESULTS: Active TMS significantly reduced right amygdala threat reactivity compared with sham TMS. No significant effect of TMS was observed on skin conductance reactivity. From pre- to post-TMS, significant reductions in hyperarousal and total PTSD symptoms were observed across groups, but no significant differences between groups were observed. From pre-TMS to follow-up, active TMS compared with sham TMS significantly reduced hyperarousal and total PTSD symptoms. Clinical findings were found to be robust in sensitivity analyses. CONCLUSIONS: This is the first clinical trial to demonstrate that personalized fMRI-guided TMS targeting the threat neurocircuitry reduces amygdala threat reactivity and improves long-term PTSD symptoms at follow-up. These findings suggest the potential for a personalized approach to neuromodulation in individuals with PTSD.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. van Rooij SJH, Langhinrichsen-Rohling R, Minton ST, et al. Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial. Am J Psychiatry. 2026. PMID: 41922982. doi:10.1176/appi.ajp.20250749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。